CeriBell, Inc. (CBLL)
CBLL moved a median of 0.00% 30 minutes after news, and +0.12% by the close. How CBLL actually reacts to news — the realized, point-in-time move the market made, measured across 332 labeled events over the last three years with zero look-ahead.
CBLL’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 46% | 315 |
| 30-min | 0.00% | 49% | 329 |
| 60-min | +0.21% | 55% | 329 |
| to close | +0.12% | 52% | 327 |
| Middle 50% of CBLL reactions | -0.74% to +0.69% |
|---|---|
| Median reaction (30-min) | 0.00% |
| Measured reactions | 332 |
Half of all CeriBell, Inc. news events land between -0.74% and +0.69% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How CBLL reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Coverage initiations | 25 | -0.26% | 12% | -0.11% |
| Rating reiterations | 22 | -0.50% | 32% | -0.29% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. 4 further classes were observed with fewer than 10 measured events and are not published. See how CBLL ranks against every other measured name →
That’s how CBLL usually reacts — get an email when it moves on news →Email me when CBLL moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to CBLL's baseline. Nothing else.
Recent CBLL events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Ceribell Receives FDA 510(k) Clearance for Quantitative EEG Trending and Amplitude-Integrated EEG Analysis | Press release | GlobeNewswire | +0.10% | -2.44% | |
| Ceribell Receives FDA Clearance for Advanced Epileptiform Abnormality Detection and Artifact Reduction for Its Cloud-Based Portal, Delivering Greater Precision for Critical-Care EEG Review | Press release | GlobeNewswire | +0.00% | — | |
| Ceribell Secures CMS New Technology Add-On Payment (NTAP) for Breakthrough Point-of-Care Delirium Monitor System | Press release | GlobeNewswire | +0.44% | +1.72% | |
| Form 8-K Ceribell, Inc. For: Jul 28 | SEC filing · Form 8-K | SEC EDGAR | +0.95% | -0.95% | |
| Ceribell Expands Board of Directors with Appointments of Thomas West and Sharon O’Keefe | Press release | GlobeNewswire | -0.62% | -0.39% | |
| Ceribell to Participate in the Canaccord Genuity 46th Annual Growth Conference | Press release | GlobeNewswire | -0.62% | -0.39% | |
| Ceribell to Report Second Quarter 2026 Financial Results on August 10, 2026 | Press release | GlobeNewswire | +0.41% | -2.35% | |
| Ceribell Announces New Critical Care Medicine Publication Reinforcing Link Between Seizure Burden Measured by Clarity AI Algorithm and Neurological Outcomes | Press release | GlobeNewswire | -0.76% | -1.20% | |
| Form 8-K Ceribell, Inc. For: Jun 02 | SEC filing · Form 8-K | SEC EDGAR | -1.28% | -2.00% | |
| Ceribell to Participate in the William Blair 46th Annual Growth Stock Conference | Press release | GlobeNewswire | -0.03% | +5.28% | |
| Ceribell Reports First Quarter 2026 Financial Results | Press release | GlobeNewswire | -1.94% | -9.65% | |
| Form 10-Q Ceribell, Inc. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | -1.94% | -9.65% | |
| Form 8-K Ceribell, Inc. For: May 11 | SEC filing · Form 8-K | SEC EDGAR | -1.94% | -9.65% | |
| Ceribell to Participate in the Bank of America Securities 2026 Health Care Conference | Press release | GlobeNewswire | +0.05% | +4.78% | |
| Ceribell to Report First Quarter 2026 Financial Results on May 11, 2026 | Press release | GlobeNewswire | -0.12% | -1.23% | |
| Form ARS Ceribell, Inc. For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | — | +0.24% | |
| Form DEF 14A Ceribell, Inc. For: Jun 02 | SEC filing · Form DEF | SEC EDGAR | +0.00% | +0.24% | |
| Form DEFA14A Ceribell, Inc. | SEC filing · Form DEFA14A | SEC EDGAR | +0.00% | +0.24% | |
| Ceribell Reports Fourth Quarter and Full Year 2025 Financial Results | Press release | GlobeNewswire | -0.11% | +0.69% | |
| Form 10-K Ceribell, Inc. For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | -0.11% | +0.69% | |
| Form 8-K Ceribell, Inc. For: Feb 24 | SEC filing · Form 8-K | SEC EDGAR | -0.11% | +0.69% | |
| Form S-8 Ceribell, Inc. | SEC filing · Form S-8 | SEC EDGAR | -0.11% | +0.69% | |
| Ceribell to Participate in Upcoming March Investor Conferences | Press release | GlobeNewswire | +0.50% | +1.96% | |
| Ceribell to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 | Press release | GlobeNewswire | -0.65% | -1.72% | |
| Ceribell Receives FDA Breakthrough Device Designation for LVO Stroke Detection and Monitoring Solution | Press release | GlobeNewswire | -2.81% | -7.92% | |
| Form 8-K Ceribell, Inc. For: Jan 05 | SEC filing · Form 8-K | SEC EDGAR | +0.04% | -6.09% | |
| Form 8-K Ceribell, Inc. For: Dec 30 | SEC filing · Form 8-K | SEC EDGAR | -2.81% | -7.92% | |
| Ceribell to Participate in the 44th Annual J.P. Morgan Healthcare Conference | Press release | GlobeNewswire | -0.92% | +0.60% | |
| AI Diagnostics Hit Critical Mass as Hospitals Race to Cut Costs | Press release | PR Newswire | -0.20% | +2.80% | |
| Form 8-K Ceribell, Inc. For: Dec 11 | SEC filing · Form 8-K | SEC EDGAR | -0.07% | +0.12% | |
| Ceribell Receives FDA 510(k) Clearance for First-of-its-Kind Delirium Monitoring Solution | Press release | GlobeNewswire | +1.08% | -6.23% | |
| Form 8-K Ceribell, Inc. For: Dec 09 | SEC filing · Form 8-K | SEC EDGAR | +1.08% | -6.23% | |
| Form EFFECT Ceribell, Inc. | SEC filing · Form EFFECT | SEC EDGAR | +0.09% | +1.08% | |
| Ceribell Receives FDA 510(k) Clearance for Use of Clarity? Algorithm for Neonates | Press release | GlobeNewswire | -0.65% | +4.71% | |
| Form 8-K Ceribell, Inc. For: Nov 24 | SEC filing · Form 8-K | SEC EDGAR | +0.06% | +0.50% | |
| Ceribell to Participate in the Piper Sandler 37th Annual Healthcare Conference | Press release | GlobeNewswire | +1.09% | -1.09% | |
| Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum | Press release | GlobeNewswire | +0.43% | +4.26% | |
| Ceribell Reports Third Quarter 2025 Financial Results | Press release | GlobeNewswire | +4.77% | +7.09% | |
| Form 10-Q Ceribell, Inc. For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | +4.77% | +7.09% | |
| Form 8-K Ceribell, Inc. For: Nov 04 | SEC filing · Form 8-K | SEC EDGAR | +4.77% | +7.09% | |
| Form S-3 Ceribell, Inc. | SEC filing · Form S-3 | SEC EDGAR | +4.77% | +7.09% | |
| Ceribell to Report Third Quarter 2025 Financial Results on November 4, 2025 | Press release | GlobeNewswire | +1.69% | +0.60% | |
| Form 8-K Ceribell, Inc. For: Sep 22 | SEC filing · Form 8-K | SEC EDGAR | +0.90% | -0.65% | |
| Form 8-K Ceribell, Inc. For: Sep 17 | SEC filing · Form 8-K | SEC EDGAR | -1.63% | -0.89% | |
| Medtech Leader Erica Rogers Joins Ceribell Board of Directors | Press release | GlobeNewswire | -1.63% | -0.89% | |
| Ceribell Reports Second Quarter 2025 Financial Results | Press release | GlobeNewswire | -6.67% | -14.80% | |
| Form 10-Q Ceribell, Inc. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -6.67% | -14.80% | |
| Form 8-K Ceribell, Inc. For: Aug 05 | SEC filing · Form 8-K | SEC EDGAR | -6.67% | -14.80% | |
| Ceribell to Participate in the Canaccord Genuity 45th Annual Growth Conference | Press release | GlobeNewswire | +0.30% | +0.74% | |
| Ceribell to Report Second Quarter 2025 Financial Results on August 5, 2025 | Press release | GlobeNewswire | +0.10% | +1.03% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the CBLL section they belong to.
Where else CBLL is measured.
CBLL earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is CeriBell, Inc.'s median reaction calculated?
Every labeled CBLL news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 332 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 49% of CBLL's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does CBLL's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.